GGrantIndex
Sort

146,196 grants matching diabetes

ETIB Clinical Research Core

$2,479,411
Ronald Gress · Division Of Basic Sciences - Nci · ZID · FY2011 · CA

Ancillary to HCHS/SOL: Sociocultural Factors and CVD risk/prevalence in Hispanics

$2,478,412
Linda C Gallo · San Diego State University · RC2 · FY2009 · HL

General Clinical Research Center

$2,478,297
Sheldon M Retchin · Virginia Commonwealth University · M01 · FY2007 · RR

Control Systems for Artificial Pancreas Use During and After Exercise

$2,478,076
Ali Cinar · Illinois Institute Of Technology · DP3 · FY2013 · DK

Ketone Monitoring Approaches for DKA Risk Mitigation in People with T1D on Adjunctive SGLT2 Inhibitors (KARMA)

$2,477,577
Richard E Pratley · Adventhealth Orlando · U01 · FY2025 · DK

Integrating lifecourse approaches, biologic and digital phenotypes in support of heart and lung disease epidemiologic research

$2,477,414
Jorge Eduardo Chavarro · Harvard School Of Public Health · U01 · FY2023 · HL

PREVENTABLE Data Coordinating Center

$2,476,924
Bradley G Hammill · Duke University · U19 · FY2019 · AG

Clinical Center for NIH's Nutrition for Precision Health: The All Of Us New England Research Collaborative

$2,475,248
Sai Krupa Das · Tufts University Boston · UG1 · FY2024 · HD

Southeast Collaborative for Innovative and Equitable Solutions to Chronic Disease Disparities

$2,474,638
Consuelo Hopkins Wilkins · Vanderbilt University Medical Center · P50 · FY2022 · MD

The POINTER Neurovascular Ancillary Study

$2,474,352
Tina E Brinkley · Wake Forest University Health Sciences · R01 · FY2020 · AG

CCR Genomics Core

$2,473,796
Elizabeth Conner · Division Of Basic Sciences - Nci · ZIC · FY2021 · CA

Phthalate Mixture induced Epigenetic Regulations in Adipose Tissues

$2,472,661
Mahua Choudhury · Texas A&M University Health Science Ctr · R01 · FY2025 · ES

Autocoids in Hypertension: Pathogenesis and End Organ Damage

$2,472,318
Pablo A Ortiz · Henry Ford Health System · P01 · FY2017 · HL

Autocoids in Hypertension: Pathogenesis and End Organ Damage

$2,472,318
Oscar A. Carretero · Henry Ford Health System · P01 · FY2016 · HL

Treatment of Preserved Systolic Function with an Aldosterone Antagonist

$2,472,282
Rebecca Li · New England Research Institutes, Inc. · N01 · FY2013 · HL

Life Course Energy Balance and Breast Cancer Risk in Black/White Women Under 50

$2,472,271
Ellen M Velie · Michigan State University · R01 · FY2010 · CA

Hypothalamic neuronal circuits controlling survival behaviors

$2,471,993
Yeka Aponte · National Institute On Drug Abuse · ZIA · FY2023 · DA

Metabolic Basis of Disease

$2,471,896
Jacqueline M Stephens · Lsu Pennington Biomedical Research Ctr · P20 · FY2020 · GM

Cancer Risk in Human Populations

$2,471,847
Debra Silverman · Division Of Cancer Epidemiology And Genetics · ZIA · FY2018 · CA

Glycoconjugates and Cardiovascular Disease

$2,470,521
Gerald Warren Hart · Johns Hopkins University · P01 · FY2015 · HL

Institute for Integration of Medicine & Science: A Partnership to Improve Health

$2,468,749
Robert A Clark · University Of Texas Hlth Science Center · UL1 · FY2013 · TR

Role of G protein-coupled receptors in regulating glucose and energy homeostasis

$2,467,412
Jurgen Wess · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2015 · DK

Cardiovascular Disease and Diabetes Program Project

$2,466,809
Karin E. Bornfeldt · University Of Washington · P01 · FY2018 · HL

Cardiovascular Disease and Diabetes Program Project

$2,466,716
Karin E. Bornfeldt · University Of Washington · P01 · FY2017 · HL

Human Translational Studies of Inflammation and Cardiometabolic Diseases: The Psoriasis, Atherosclerosis and Cardiometabolic disease (PACI) Initiative

$2,466,198
Nehal Mehta · National Heart, Lung, And Blood Institute · ZIA · FY2014 · HL